proof-hd: phase iii trial of oral s1r agonist pridopidine for the treatment of huntington’s disease
Published 1 year ago • 563 plays • Length 5:38Download video MP4
Download video MP3
Similar videos
-
3:03
pridopidine application beyond huntington’s disease
-
1:05:12
hsc x hdsa research webinar: data from the phase 3 proof hd trial of pridopidine
-
3:35
phase ii piovt-hd trial of ptc518 in early huntington's disease
-
3:19
proof-hd: about pridopidine
-
57:58
hdsa research webinar: all you need to know about proof-hd
-
1:02:15
webinar prilenia - all you need to know about proof hd
-
30:19
looking back, looking forward: the proof-hd phase 3 trial
-
17:58
prilenia proof hd update: dr michael hayden
-
5:33
about proof-hd (full length)
-
3:58
proof-hd: about proof-hd (ongoing)
-
3:12
proof-hd study enrolling huntington disease patients
-
1:01:45
hdsa research webinar: proof-hd
-
2:40
what is proof-hd?
-
5:33
about proof-hd (full length)
-
1:58
proof-hd: about clinical trials
-
4:24
ongoing trials with importance for huntington’s disease
-
6:29
proof-hd: pivotal huntington disease trial underway
-
1:58
proof-hd huntington disease trial is fully recruited and ahead of schedule
-
1:46
huntington's disease integrated staging system (hd-iss) for clinical research